BackgroundCheck.run
Search For

Jeffrey S Kiel, 683338 Noble Fir Trce SW, Gainesville, GA 30504

Known as:
Jeffrey Diann Kiel Jeffrey D Kiel Jeff S Kiel Jeffery S Kiel Jeffrey Kiei Jeffrey Krel
Related to:
Tracy L Johnson 55

Jeffrey Kiel Phones & Addresses

3338 Noble Fir Trce SW, Gainesville, GA 30504    770-5305796   

4253 Cherokee Rd, Gainesville, GA 30504   

Flowery Branch, GA   

Mechanicsburg, PA   

Houston, TX   

Jasper, GA   

Hampstead, NC   

Wilmington, NC   

Get Report
Control this profile

Mentions for Jeffrey S Kiel

Career records & work history

Lawyers & Attorneys

Jeffrey Kiel Photo 1

Jeffrey Kiel - Lawyer

ISLN:
911984512
Admitted:
1980

Medicine Doctors

Jeffrey J. Kiel

Specialties:
Internal Medicine
Work:
Northern Internal Medicine
1920 S Straits Hwy, Indian River, MI 49749
231-2380160 (phone)
Education:
Medical School
Michigan State University College of Osteopathic Medicine
Graduated: 1988
Languages:
English
Description:
Dr. Kiel graduated from the Michigan State University College of Osteopathic Medicine in 1988. He works in Indian River, MI and specializes in Internal Medicine.

Publications & IP owners

Us Patents

Lice Removing Composition

US Patent:
6350724, Feb 26, 2002
Filed:
Aug 13, 1999
Appl. No.:
09/373951
Inventors:
Jeffrey S. Kiel - Gainesville GA
Jeffrey H. Ping - Gainesville GA
Assignee:
Effcon Laboratories, Inc. - Marietta GA
International Classification:
A61K 750
US Classification:
510119, 510420, 424405, 424406, 424 701, 514512, 514703, 514739
Abstract:
The present invention provides a composition, and a method of use thereof, that is pesticide-free and yet is capable of cleansing an individual of a pest infestation. The composition of the present invention consists essentially of an acid, an alcohol, an aqueous detergent and water. The composition is used in the removal of pests and their ova from infested individuals. Preferably, the composition of the present invention takes the form of a shampoo and is used to cleanse individuals of lice infestations. In use, the composition is applied to hair and allowed to remain in contact with the hair and scalp for a period of time, called the residence time. After the residence time, the composition is rinsed from the hair. Then, the hair is combed with a suitable nit comb. These treatment steps may be repeated as necessary and appropriate to effectuate the removal of the pest infestation.

Process For Preparing Tannate Liquid And Semi-Solid Dosage Forms

US Patent:
6869618, Mar 22, 2005
Filed:
Apr 9, 2002
Appl. No.:
10/119285
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Gainesville GA, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
A61K009/14
A01N025/00
A01N033/02
A01N043/40
US Classification:
424489, 514849, 514850, 514853, 514855, 514937, 514653, 514352
Abstract:
An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or purification is then added to a liquid or semi-solid medium composed of thickening, suspending, coloring, sweetening and flavoring agents, with stirring. Thereafter, preservatives, pH-adjusting and anti-caking agents in a suitable solvent are mixed with the liquid or semi-solid medium to generate a therapeutic dosage form.

Process For Preparing Tannate Liquid And Semi-Solid Dosage Forms

US Patent:
7094429, Aug 22, 2006
Filed:
Aug 19, 2004
Appl. No.:
10/921438
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Port Jefferson NY, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
A61K 9/14
A01N 33/02
A01N 43/40
US Classification:
424489, 514849, 514850, 514853, 514855, 514937, 514653, 514352
Abstract:
An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or purification is then added to a liquid or semi-solid medium composed of thickening, suspending, coloring, sweetening and flavoring agents, with stirring. Thereafter, preservatives, pH-adjusting and anti-caking agents in a suitable solvent are mixed with the liquid or semi-solid medium to generate a therapeutic dosage form.

Process For Preparing Tannate Tablet, Capsule Or Other Solid Dosage Forms

US Patent:
7273623, Sep 25, 2007
Filed:
Oct 10, 2002
Appl. No.:
10/269027
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Gainesville GA, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
A61K 9/14
A61K 9/20
A61K 9/48
US Classification:
424489, 424451, 424452, 424464, 424465
Abstract:
An active pharmaceutical ingredient is combined with tannic acid to form a tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or purification is then blended with pharmaceutically acceptable excipients to form a granulate which is processed into a tablet or capsule to generate a therapeutic solid dosage form.

Phenolic Acid Salts Of Gabapentin In Liquid And/Or Semi-Solid Dosage Forms And Methods Of Use

US Patent:
7390922, Jun 24, 2008
Filed:
Mar 22, 2004
Appl. No.:
10/806260
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Port Jefferson NY, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
C07C 229/28
US Classification:
562507
Abstract:
The present invention relates to pharmaceutical compositions of gabapentin tannate, processes for production of those compositions and methods of use of those compositions. The present invention provides a novel process for preparation of the tannate salt of gabapentin in liquid or semi-solid dosage form for human and veterinary pharmaceutical use. Tannate salts of active pharmaceutical ingredients are used in sustained release applications and to improve certain organoleptic properties such as taste. The process may utilize either natural or synthetic tannic acid.

Phenolic Acid Salts Of Gabapentin In Solid Dosage Forms And Methods Of Use

US Patent:
7456312, Nov 25, 2008
Filed:
Mar 22, 2004
Appl. No.:
10/805806
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Port Jefferson NY, US
Assignee:
Kiel Laborities, Inc. - Gainesville GA
International Classification:
C07C 229/28
A61K 31/195
US Classification:
562507, 514561
Abstract:
The present invention relates to pharmaceutical compositions of gabapentin tannate in solid dosage form, processes for production of those compositions and methods of use of those compositions. Tannate salts of active pharmaceutical ingredients are used in sustained release applications and to improve certain organoleptic properties such as taste. The process may utilize either natural or synthetic tannic acid.

Process For Preparing Phenolic Acid Salts Of Gabapentin

US Patent:
7550628, Jun 23, 2009
Filed:
Mar 22, 2004
Appl. No.:
10/806022
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Port Jefferson NY, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
C07C 61/08
A61K 31/195
US Classification:
562507, 514561
Abstract:
The present invention provides a novel process for preparation of the tannate salt of gabapentin for human and veterinary pharmaceutical use. Tannate salts of active pharmaceutical ingredients are used in sustained release applications and to improve certain organoleptic properties such as taste. However, the prior art neither discloses nor suggests the preparation of gabapentin tannate. The process for preparing gabapentin tannate includes the mixing of gabapentin and tannic acid together in the presence of one or more solvents. The method may further include the step of selecting the one or more solvents from a group consisting of purified water, ethanol, glycerin, propylene glycol, diethylether, methylene chloride, acetone, isopropyl alcohol and mixtures thereof. The process may also include the steps of isolating and purifying the tannate salt. This may be accomplished by filtration, drying, centrifugation and lyophilization.

Phenolic Acid Salts Of Gabapentin In Solid Dosage Forms And Methods Of Use

US Patent:
7786168, Aug 31, 2010
Filed:
Jun 13, 2008
Appl. No.:
12/138945
Inventors:
Jeffrey S. Kiel - Gainesville GA, US
H. Greg Thomas - Villa Rica GA, US
Narasimhan Mani - Port Jefferson NY, US
Assignee:
Kiel Laboratories, Inc. - Gainesville GA
International Classification:
A61K 31/196
C07C 61/08
US Classification:
514561, 562507
Abstract:
The present invention relates to pharmaceutical compositions of gabapentin tannate in solid dosage form, processes for production of those compositions and methods of use of those compositions. Tannate salts of active pharmaceutical ingredients are used in sustained release applications and to improve certain organoleptic properties such as taste. The process may utilize either natural or synthetic tannic acid.

Public records

Vehicle Records

Jeffrey Kiel

Address:
3338 Noble Fir Trce, Gainesville, GA 30504
Phone:
770-5341072
VIN:
SCFAB05D09GE00482
Make:
ASTON MARTIN
Model:
DBS
Year:
2009

Possible Relatives

Cynthia L Kiel  David H Kiel  Deanna E Kiel  Dale A Kiel  Dana E Kiel  Daniel J Kiel  Aaron R Kiel  Jeffrey P Johnson  Jeffrey Stamps  Jeffrey Standard 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.